Methionine sulfoxide reductase A rs10903323 G/A polymorphism is associated with increased risk of coronary artery disease in a Chinese population

Clinical Biochemistry

Volumn 46, Issue 16-17, 2013, Pages 1668-1672

  Gu, Haiyong ^a   Chen, Weiqiang ^b   Yin, Jun ^a   Chen, Suocheng ^a   Zhang, Jian ^b   Gong, Jie ^c  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Molecular epidemiology; MSRA; Polymorphisms

Indexed keywords

METHIONINE SULFOXIDE REDUCTASE A; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CAD; CARDIOVASCULAR DISEASE; CI; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; LD; LINKAGE DISEQUILIBRIUM; METHIONINE SULFOXIDE REDUCTASE A; MOLECULAR EPIDEMIOLOGY; MSRA; ODDS RATIO; OR; POLYMORPHISMS; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; METHIONINE SULFOXIDE REDUCTASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886413435     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.07.011     Document Type: Article

References (23)

1. Cutler D.M., McClellan M. Is technological change in medicine worth it?. Health Aff (Millwood) 2001, 20:11-29.
2. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
3. Okrainec K., Banerjee D.K., Eisenberg M.J. Coronary artery disease in the developing world. Am Heart J 2004, 148:7-15.
4. Takada Y., Mukhopadhyay A., Kundu G.C., Mahabeleshwar G.H., Singh S., Aggarwal B.B. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 2003, 278:24233-24241.
5. Starr J.M., Shiels P.G., Harris S.E., Pattie A., Pearce M.S., Relton C.L., et al. Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79years from the 1932 Scottish Mental Survey. Mech Ageing Dev 2008, 129:745-751.
6. Hotta K., Nakamura M., Nakamura T., Matsuo T., Nakata Y., Kamohara S., et al. Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population. J Hum Genet 2010, 55:738-742.
7. Garcia-Bermudez M., Lopez-Mejias R., Gonzalez-Juanatey C., Castaneda S., Miranda-Filloy J.A., Blanco R., et al. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. Scand J Rheumatol 2012, 41:350-353.
8. De Luca A., Sanna F., Sallese M., Ruggiero C., Grossi M., Sacchetta P., et al. Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype. Proc Natl Acad Sci U S A 2010, 107:18628-18633.
9. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
10. Feldmann M., Brennan F.M., Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 1998, 17:217-228.
11. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996, 14:397-440.
12. Vincenti V., Cassano C., Rocchi M., Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996, 93:1493-1495.
13. Stevens A., Soden J., Brenchley P.E., Ralph S., Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003, 63:812-816.
14. Shahbazi M., Fryer A.A., Pravica V., Brogan I.J., Ramsay H.M., Hutchinson I.V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002, 13:260-264.
15. Watson C.J., Webb N.J., Bottomley M.J., Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12:1232-1235.
16. Ruiz M.T., Biselli P.M., Maniglia J.V., Pavarino-Bertelli E.C., Goloni-Bertollo E.M. Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population. Braz J Med Biol Res 2010, 43:127-133.
17. Biselli P.M., Guerzoni A.R., de Godoy M.F., Pavarino-Bertelli E.C., Goloni-Bertollo E.M. Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 2008, 23:371-375.
18. Zhou Y., Li N., Zhuang W., Wu X. Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog 2011, 50:184-188.
19. Mihci E., Ozkaynak S.S., Sallakci N., Kizilay F., Yavuzer U. VEGF polymorphisms and serum VEGF levels in Parkinson's disease. Neurosci Lett 2011, 494:1-5.
20. Gong D., Gu H., Zhang Y., Gong J., Nie Y., Wang J., et al. Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80G>A polymorphisms are associated with an increased risk of conotruncal heart defects. Clin Chem Lab Med 2012, 50:1455-1461.
21. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
22. Prentice H.M., Moench I.A., Rickaway Z.T., Dougherty C.J., Webster K.A., Weissbach H. MsrA protects cardiac myocytes against hypoxia/reoxygenation induced cell death. Biochem Biophys Res Commun 2008, 366:775-778.
23. Martin J.E., Alizadeh B.Z., Gonzalez-Gay M.A., Balsa A., Pascual-Salcedo D., Fernandez-Gutierrez B., et al. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. Arthritis Rheum 2010, 62:3183-3190.